000 | 01629 a2200421 4500 | ||
---|---|---|---|
005 | 20250518011646.0 | ||
264 | 0 | _c20190308 | |
008 | 201903s 0 0 eng d | ||
022 | _a1521-0669 | ||
024 | 7 |
_a10.1080/08880018.2018.1538277 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVyas, Chintan | |
245 | 0 | 0 |
_aExperience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity. _h[electronic resource] |
260 |
_bPediatric hematology and oncology _c |
||
300 |
_a331-340 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aAsparaginase _xadministration & dosage |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aDaunorubicin _xadministration & dosage |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aDrug Monitoring |
650 | 0 | 4 |
_aDrugs, Generic _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aVincristine _xadministration & dosage |
700 | 1 | _aJain, Sandeep | |
700 | 1 | _aKapoor, Gauri | |
700 | 1 | _aMehta, Anurag | |
700 | 1 | _aTakkar Chugh, Parul | |
773 | 0 |
_tPediatric hematology and oncology _gvol. 35 _gno. 5-6 _gp. 331-340 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/08880018.2018.1538277 _zAvailable from publisher's website |
999 |
_c29102811 _d29102811 |